Towards a Molecular Signature of Neutrophil Priming
Towards a Molecular Signature of Neutrophil Priming
批准号:
7708311
负责人:
ARTHUR Robert SALOMON
金额:
$20.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-17 至 2011-06-30
关键词:
AddressAffectApplications GrantsArtsBiochemicalBone MarrowCell LineCellsCessation of lifeCollaborationsComplexDataDetectionDevelopmentDiseaseDoseEnvironmental Risk FactorEukaryotic CellEventExperimental DesignsExposure toFunctional disorderFutureGlobal ChangeGoalsHost DefenseHumanImageryInfectionInflammationInflammatoryInflammatory ResponseInjuryLaboratoriesLeadLifeLipopolysaccharidesMass Spectrum AnalysisMediator of activation proteinMethodsModelingMolecularMolecular ProfilingNoiseOrgan failurePathway interactionsPatientsPeptidesPhosphorylationPhosphorylation SitePlatelet Activating FactorProtein ArrayProteinsProteomePublishingReactive Oxygen SpeciesReagentReceptor ActivationRelative (related person)Reperfusion InjuryReportingRestRoleSamplingSepsisSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSiteSystemSystems AnalysisT-LymphocyteTechniquesTechnologyTestingTherapeuticTimeTissuesTraumaTyrosine PhosphorylationTyrosine Phosphorylation SiteWorkcytokinedesignin vivoinjury and repairmast cellmethionyl-leucyl-phenylalaninemicrobialnetwork modelsneutrophilnovel diagnosticspublic health relevanceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neutrophil priming is an integral aspect of a well-regulated inflammatory response and is the first step in controlling microbial infection and repair of injury. In this model, an initial injury "primes" neutrophils such that a secondary insult, which would otherwise be tempered in an unprimed cell, now results in an exaggerated inflammatory response. The excessive and unregulated release of cytokines and toxic oxygen radicals causes damage to adjacent tissues leading to tissue dysfunction, organ failure and death. The precise molecular pathways initiated upon priming of human neutrophils are poorly understood. The present proposal focuses on the application of quantitative phosphoproteomic technology to understand the unique proteome-wide tyrosine phosphorylation events associated with human neutrophil priming by exposure to low dose N-formyl-met-leu-phe, lipopolysaccharide or platelet activating factor. Using currently available quantitative phosphoproteomic technology and expertise with primary human neutrophils in our laboratories, we will sample primed neutrophils at various time points and quantify relative changes in wide-scale tyrosine phosphorylation from total cell lysates of cellular peptides. Information to be derived from this project include: global identification of tyrosine phosphorylation events that occur over time after neutrophil priming; visualization of the network of signal transduction pathways that are activated in the primed neutrophils; comparison of activation events that take place over time from neutrophils primed with different proinflammatory mediators. This type of quantitative analysis of global tyrosine phosphorylation sites during a time course of neutrophil priming along with traditional biochemical analysis will permit the construction of a signaling pathway network model for neutrophil priming. Together these findings will test the hypothesis that the primed state of the neutrophil includes signaling events that are common among proinflammatory mediators and can be presented as a molecular signature of this fundamental cellular response. Given that responding neutrophils must interpret a number of signals at a site of inflammation, the results from these studies may assist in the development of novel diagnostic or therapeutic reagents aimed at limiting the auto-inflammatory tissue damage patients suffer as a result of sepsis and trauma. PUBLIC HEALTH RELEVANCE: Neutrophil priming is an integral aspect of a well-regulated inflammatory response and is the first step in controlling microbial infection and repair of injury. The precise molecular pathways initiated upon priming of human neutrophils are poorly understood. In this proposal we introduce modern methods in quantitative mass spectrometry to facilitate the characterization of the cellular signaling pathways initiated upon neutrophil priming by a variety of agents by providing a global view of the phosphorylation state of normal and primed cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteomics Core
-
批准号:10428137
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2011
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Proteomics Core
-
批准号:10615815
-
项目类别:
-
资助金额:$13.81万
-
财政年份:2011
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of Feedback Networks in T cell signaling
-
批准号:10132943
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of T Cell Activation Pathways
-
批准号:8468632
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of T Cell Activation Pathways
-
批准号:8277233
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of T Cell Activation Pathways
-
批准号:8079748
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of T Cell Activation Pathways
-
批准号:7887159
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of Feedback Networks in T cell signaling
-
批准号:9915845
-
项目类别:
-
资助金额:$40.8万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Phosphoproteomic Analysis of T Cell Activation Pathways
-
批准号:8661694
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2010
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
HIGH-THROUGHPUT PROTEOMIC ANALYSIS OF SIGNALING PATHWAYS
-
批准号:7959357
-
项目类别:
-
资助金额:$23.95万
-
财政年份:2009
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
Towards a Molecular Signature of Neutrophil Priming
-
批准号:7895611
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2009
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
HIGH-THROUGHPUT PROTEOMIC ANALYSIS OF SIGNALING PATHWAYS
-
批准号:7720317
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2008
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
HIGH-THROUGHPUT PROTEOMIC ANALYSIS OF SIGNALING PATHWAYS
-
批准号:7609785
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2007
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
HIGH-THROUGHPUT PROTEOMIC ANALYSIS OF SIGNALING PATHWAYS
-
批准号:7381156
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2006
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
COBRE Center for Cancer Research Development
-
批准号:9266452
-
项目类别:
-
资助金额:$15.1万
-
财政年份:--
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
COBRE Center for Cancer Research Development
-
批准号:9057097
-
项目类别:
-
资助金额:$15.77万
-
财政年份:--
-
负责人:ARTHUR Robert SALOMON
-
依托单位:
海外基金